Innovating Works

EUROPEAN HEMATOLOGY ASSOCIATION

Desconocido
InnoCAR-T: Innovative design and implementation of next generation Point of Care CAR T InnoCAR-T is a Doctoral Network designed to provide training and carry out breakthrough research on the high impact field of Chimeric Antige...
2022-07-14 - 2026-12-31 | Financiado
T2EVOLVE: Accelerating Development and Improving Access to CAR and TCR engineered T cell therapy EUROPEAN HEMATOLOGY ASSOCIATION participó en un H2020: H2020-JTI-IMI2-2019-18-two-stage Immune cells that are empowered by gene-engineering to seek and destroy cancer cells (engineered T cell therapy) constitute a transformative...
2020-11-24 - 2025-12-31 | Financiado
HARMONY PLUS: HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY PLUS EUROPEAN HEMATOLOGY ASSOCIATION participó en un H2020: H2020-JTI-IMI2-2019-19-single-stage Haematological malignancies (HM), also known as blood cancers, are a heterogeneous and complex group of multicausal diseases that can’t be e...
2020-05-26 - 2024-03-31 | Financiado
HARMONY: Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY Sofia ref.... EUROPEAN HEMATOLOGY ASSOCIATION participó en un H2020: H2020-JTI-IMI2-2015-06-two-stage Despite significant recent progress in the field of hematological malignancies (HMs), with increasing survival rates and improvement in qual...
2016-12-22 - 2023-06-30 | Financiado
PROFILE: Innovative training network Immunoprofile directed stratification of patients with the autoimmune d... EUROPEAN HEMATOLOGY ASSOCIATION participó en un H2020: H2020-MSCA-ITN-2015 The PROFILE Innovative European Industrial Doctoral programme will develop improved tools for stratification of patients with the autoimmune...
2015-08-03 - 2019-09-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.